Stepwise mitral valve repair for Barlow's disease via a minimally invasive approach.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 19 02 2020
revised: 15 04 2020
accepted: 27 04 2020
pubmed: 10 5 2020
medline: 3 11 2020
entrez: 9 5 2020
Statut: ppublish

Résumé

Mitral regurgitation (MR) in Barlow's disease is complicated because of its mixed pathophysiology, leaflet billowing with or without organic prolapse, and abnormal annular dynamics that cause functional prolapse. Complex repair techniques, including aggressive leaflet resection and implantation of multiple artificial chordae, are conventionally performed; nevertheless, these are technically demanding, especially when performed using a minimally invasive approach. We aimed to standardize the repair technique for Barlow's disease and developed stepwise repair techniques. Of 292 patients who underwent isolated minimally invasive mitral valve repair for MR, 29 patients (seven females, age 49 ± 10 years) were found to have Barlow's disease. Our repair technique consists of the following three steps: (a) stabilization of the mitral annulus by placing annuloplasty ring sutures; (b) distinction between organic and functional prolapse by a saline injection test; and (c) targeted repair for organic prolapse by leaflet resection or chordal replacement. Surgical techniques included leaflet resection in 22 patients, chordal replacement in 19 patients, and ring annuloplasty only in one patient. These procedures were applied to the anterior leaflet in one, posterior leaflet in eight, and both leaflets in 19 patients. The median annuloplasty ring size was 34 mm. The repair success rate was 100%. No patients developed moderate or greater MR during a mean follow-up period of 36 ± 21 months. A stepwise repair strategy facilitates mitral valve repair in patients with Barlow's disease and provides excellent outcomes even via a minimally invasive approach.

Sections du résumé

BACKGROUND AND AIM OBJECTIVE
Mitral regurgitation (MR) in Barlow's disease is complicated because of its mixed pathophysiology, leaflet billowing with or without organic prolapse, and abnormal annular dynamics that cause functional prolapse. Complex repair techniques, including aggressive leaflet resection and implantation of multiple artificial chordae, are conventionally performed; nevertheless, these are technically demanding, especially when performed using a minimally invasive approach. We aimed to standardize the repair technique for Barlow's disease and developed stepwise repair techniques.
METHODS METHODS
Of 292 patients who underwent isolated minimally invasive mitral valve repair for MR, 29 patients (seven females, age 49 ± 10 years) were found to have Barlow's disease. Our repair technique consists of the following three steps: (a) stabilization of the mitral annulus by placing annuloplasty ring sutures; (b) distinction between organic and functional prolapse by a saline injection test; and (c) targeted repair for organic prolapse by leaflet resection or chordal replacement.
RESULTS RESULTS
Surgical techniques included leaflet resection in 22 patients, chordal replacement in 19 patients, and ring annuloplasty only in one patient. These procedures were applied to the anterior leaflet in one, posterior leaflet in eight, and both leaflets in 19 patients. The median annuloplasty ring size was 34 mm. The repair success rate was 100%. No patients developed moderate or greater MR during a mean follow-up period of 36 ± 21 months.
CONCLUSIONS CONCLUSIONS
A stepwise repair strategy facilitates mitral valve repair in patients with Barlow's disease and provides excellent outcomes even via a minimally invasive approach.

Identifiants

pubmed: 32383283
doi: 10.1111/jocs.14615
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1471-1476

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

Lawrie GM. Barlow disease: Simple and complex. J Thorac Cardiovasc Surg. 2015;150:1078-1081.
Lawrie GM, Earle EA, Earle NR. Nonresectional repair of the Barlow mitral valve: importance of dynamic annular evaluation. Ann Thorac Surg. 2009;88:1191-1196.
Lawrie GM, Zoghbi W, Little S, et al. One hundred percent reparability of degenerative mitral regurgitation: intermediate-term results of a dynamic engineered approach. Ann Thorac Surg. 2016;101:5786-5784.
Sakaguchi T, Totsugawa T, Kuinose M, et al. Minimally invasive mitral valve repair through right minithoracotomy-11-year single institute experience. Circ J. 2018;82:1705-1711.
Asai T, Kinoshita T, Hosoba S, et al. Butterfly resection is safe and avoids systolic anterior motion in posterior leaflet prolapase repair. Ann Thorac Surg. 2011;92:2097-2102.
Tabata M, Kasegawa H, Fukui T, Shimizu A, Sato Y, Takanashi S. Long-term outcomes of artificial chordal replacement with tourniquet technique in mitral valve repair: a single-center experience of 700 cases. J Thorac Cardiovasc Surg. 2014;148:2033-2038.
Sakaguchi T, Totsugawa T, Tamura K, Yoshitaka H. Extended neochord weaving technique for degenerative mitral valve disease. J Thorac Cardiovasc Surg. 2016;152:1626-1628.
Miura T, Ariyoshi T, Tanigawa K, et al. Technical aspects of mitral valve repair in Barlow's valve with prolapse of both leaflets: triangular resection for excess tissue, sophisticated chordal replacement, and their combination (the restoration technique). Gen Thorac Cardiovasc Surg. 2015;63:61-70.
Ben Zekry S, Spiegelstein D, Sternik L, et al. Simple repair approach for mitral regurgitation in Barlow disease. J Thorac Cardiovasc Surg. 2015;150:1071.e1-1077.e1.
Tomšič A, Hiemstra YL, Bissessar DD, et al. Mitral valve repair in Barlow's disease with bileaflet prolapse: the effect of annular stabilization on functional mitral valve leaflet prolase. Int Cardiovasc Thorac Surg. 2018;26:559-565.

Auteurs

Taichi Sakaguchi (T)

Department of Cardiovascular Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Toshinori Totsugawa (T)

Department of Cardiovascular Surgery, The Sakakibara Heart Institute of Okayama, Okayama, Japan.

Akihiro Hayashida (A)

Department of Cardiology, The Sakakibara Heart Institute of Okayama, Okayama, Japan.

Masaaki Ryomoto (M)

Department of Cardiovascular Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Naosumi Sekiya (N)

Department of Cardiovascular Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Kentaro Tamura (K)

Department of Cardiovascular Surgery, The Sakakibara Heart Institute of Okayama, Okayama, Japan.

Arudo Hiraoka (A)

Department of Cardiovascular Surgery, The Sakakibara Heart Institute of Okayama, Okayama, Japan.

Hidenori Yoshitaka (H)

Department of Cardiovascular Surgery, The Sakakibara Heart Institute of Okayama, Okayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH